Atopic Dermatitis

Treatment with ruxolitinib cream was well tolerated and effective with no effect on blood counts or bone growth among children with atopic dermatitis, according to a study published in Annals of Allergy, Asthma & Immunology.

Adults who were taking dupilumab for their atopic dermatitis also experienced significant improvements in their mild asthma, primarily in the first 16 weeks, according to a study published in Clinical and Translational Allergy.

The FDA has approved a supplemental new drug application to expand the use of abrocitinib for adolescents with atopic dermatitis when other systemic drug products are not adequate or advisable, according to a press release.

Change is far from incremental in allergy and asthma care based on the speakers and presentations scheduled for the American Academy of Allergy, Asthma & Immunology Annual Meeting in San Antonio from Feb. 24 to 27.

MIAMI BEACH, Fla. — The past year has seen explosive development in Janus kinase inhibitors for dermatologic conditions, and it is possible they could continue to have indications throughout the specialty, according to a speaker here.

MIAMI BEACH, Fla. — Social media may contribute to the high rates of mental health problems and disorders among adolescents with acne and atopic dermatitis, according to a poster presented at South Beach Symposium.

MIAMI BEACH, Florida — In two-real world studies, Dupixent treatment led to similar rapid and sustained improvements in patients with atopic dermatitis, according to a poster presentation at South Beach Symposium.

Combination lebrikizumab and topical corticosteroids outperformed topical corticosteroids alone in the treatment of atopic dermatitis in adolescents and adults, according to a phase 3 study.

Genetic variants related to GERD heightened risks for both asthma and atopic dermatitis by 21%, according to study results published in American Journal of Respiratory and Critical Care Medicine.

Children with atopic dermatitis who received dupilumab experienced improvements in disease severity and decreases in severity-associated serum biomarkers, according to a study published in Pediatric Allergy and Immunology.